Cejemly
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Cejemly, covering 2026-02-18 to 2026-07-03. Get the full timeline:
Most recent: EMA Authorised: Cejemly (sugemalimab) — Cstone Pharmaceuticals Ireland Limited